BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33878034)

  • 1. Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma.
    Loong JH; Wong TL; Tong M; Sharma R; Zhou L; Ng KY; Yu HJ; Li CH; Man K; Lo CM; Guan XY; Lee TK; Yun JP; Ma SK
    J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 33878034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-448 inhibits stemness maintenance and self-renewal of hepatocellular carcinoma stem cells through the MAGEA6-mediated AMPK signaling pathway.
    Guo JC; Yang YJ; Zhang JQ; Guo M; Xiang L; Yu SF; Ping H; Zhuo L
    J Cell Physiol; 2019 Dec; 234(12):23461-23474. PubMed ID: 31232474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting AMP-activated kinase impacts hepatocellular cancer stem cells induced by long-term treatment with sorafenib.
    Bort A; Sánchez BG; Mateos-Gómez PA; Vara-Ciruelos D; Rodríguez-Henche N; Díaz-Laviada I
    Mol Oncol; 2019 May; 13(5):1311-1331. PubMed ID: 30959553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness.
    Bi L; Ren Y; Feng M; Meng P; Wang Q; Chen W; Jiao Q; Wang Y; Du L; Zhou F; Jiang Y; Chen F; Wang C; Tang B; Wang Y
    Cancer Res; 2021 Apr; 81(8):2015-2028. PubMed ID: 33602787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma.
    Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
    Cancer Lett; 2020 Apr; 476():48-56. PubMed ID: 32061952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calreticulin activates β1 integrin via fucosylation by fucosyltransferase 1 in J82 human bladder cancer cells.
    Lu YC; Chen CN; Chu CY; Lu J; Wang BJ; Chen CH; Huang MC; Lin TH; Pan CC; Chen SS; Hsu WM; Liao YF; Wu PY; Hsia HY; Chang CC; Lee H
    Biochem J; 2014 May; 460(1):69-78. PubMed ID: 24593306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma.
    Liang C; Fukuda T; Isaji T; Duan C; Song W; Wang Y; Gu J
    Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129870. PubMed ID: 33571582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
    Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
    J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma.
    Li HK; Mai RT; Huang HD; Chou CH; Chang YA; Chang YW; You LR; Chen CM; Lee YH
    Sci Rep; 2016 Jun; 6():28637. PubMed ID: 27344963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
    Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L
    Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells.
    Sun L; Wang L; Chen T; Shi Y; Yao B; Liu Z; Wang Y; Li Q; Liu R; Niu Y; Tu K; Liu Q
    Cell Death Dis; 2020 Feb; 11(2):95. PubMed ID: 32024815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.
    You Y; Zheng Q; Dong Y; Xie X; Wang Y; Wu S; Zhang L; Wang Y; Xue T; Wang Z; Chen R; Wang Y; Cui J; Ren Z
    Oncotarget; 2016 May; 7(22):32221-31. PubMed ID: 27050147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.
    Cheng BY; Lau EY; Leung HW; Leung CO; Ho NP; Gurung S; Cheng LK; Lin CH; Lo RC; Ma S; Ng IO; Lee TK
    Cancer Res; 2018 May; 78(9):2332-2342. PubMed ID: 29483095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma.
    Kuo HH; Lin RJ; Hung JT; Hsieh CB; Hung TH; Lo FY; Ho MY; Yeh CT; Huang YL; Yu J; Yu AL
    Sci Rep; 2017 Sep; 7(1):10750. PubMed ID: 28883415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-fucose monosaccharide of Drosophila Notch has a temperature-sensitive function and cooperates with O-glucose glycan in Notch transport and Notch signaling activation.
    Ishio A; Sasamura T; Ayukawa T; Kuroda J; Ishikawa HO; Aoyama N; Matsumoto K; Gushiken T; Okajima T; Yamakawa T; Matsuno K
    J Biol Chem; 2015 Jan; 290(1):505-19. PubMed ID: 25378397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
    Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
    Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Eyelid Meibomian Gland Deficiency in Fucosyltransferase 1 Knockout Mice.
    Yoon CH; Ryu JS; Ko JH; Kim YK; Oh JH; Chung JH; Oh JY
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.